5,422
edits
Acute respiratory distress syndrome: Difference between revisions
Acute respiratory distress syndrome (view source)
Revision as of 18:57, 27 October 2024
, 27 Octoberno edit summary
(Created page with "'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe respiratory failure. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. == Etiology == * Sepsis (most common) * Pneumonia * Aspiration of gastric content * Shock * Acute pancreatitis * Major trauma == Clinical features == * Dyspnoea, restlessness, anxiety * Altered mental status * Cyan...") |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe [[respiratory failure]]. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. | <section begin="A&IC" />'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe [[respiratory failure]]. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. | ||
== Etiology == | == Etiology == | ||
| Line 42: | Line 42: | ||
* [[ECMO]] – if all other methods of oxygenation fail | * [[ECMO]] – if all other methods of oxygenation fail | ||
* If due to COVID-19: [[Dexamethasone]] and [[tocilizumab]] | * If due to COVID-19: [[Dexamethasone]] and [[tocilizumab]] | ||
<section end="A&IC" /> | |||
[[Category:Intensive care]] | |||